文献速递急性肾损伤

尿液补体因子Ba识别危重成人持续性急性肾损伤及器官衰竭

Urine Complement Factor Ba Identifies Persistent Acute Kidney Injury and Organ Failures in Critically Ill Adults.
PubMed 文献 · Kidney Int Rep · 2024-11-25

该研究利用危重成人生物样本库,检测入ICU时及12、24小时尿液Ba水平,分析其与AKI分期及器官衰竭的关联。结果显示尿Ba随AKI分期升高而增加,持续性AKI患者尿Ba高于恢复者及无AKI者,尿Ba翻倍与持续性AKI风险增加6.6倍相关。

要点

  • 尿Ba水平随AKI分期增加而升高,可区分AKI恢复与持续性AKI。
  • 尿Ba翻倍与持续性AKI风险增加6.6倍相关。
  • 尿Ba升高与更差的器官衰竭结局相关。

核心结论

  • 尿Ba在严重AKI患者中升高,可区分AKI恢复与持续性AKI。
  • 尿Ba翻倍与持续性AKI风险增加6.6倍相关。

研究设计与样本

  • 利用危重成人生物样本库,共纳入439例患者,其中无AKI 252例、AKI 1期124例、2期43例、3期20例。
  • AKI分期基于KDIGO血清肌酐标准,持续性AKI定义为需要肾脏替代治疗或无血清肌酐恢复。
  • 尿液在ICU入科时及入科后12和24小时采集,尿Ba通过酶联免疫吸附测定定量并经自然对数转换。
  • 采用回归分析检验尿Ba与器官衰竭结局的关联,并调整年龄和APACHE-II评分。

主要发现

  • 调整协变量后,尿Ba随AKI分期增加而升高。
  • 持续性AKI患者尿Ba高于AKI恢复患者和无AKI患者。
  • 尿Ba升高与更差的器官衰竭结局相关(更少无呼吸机、无ICU、无升压药天数及更少存活天数)。

临床怎么用

  • 尿Ba或可作为危重患者持续性AKI的早期识别标志物。
  • 未来需验证这些发现并试验补体因子B抑制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Critically ill adults with acute kidney injury (AKI) have high morbidity and mortality and lack treatment options. We assessed the association between complement activation (urine Ba fragment levels), and AKI and organ failures. METHODS: A biorepository of critically ill adults was leveraged. AKI staging was based on the Kidney Disease Improving Global Outcomes serum creatinine (sCr) criteria. AKI recovery was defined as sCr reduction to <0.3 mg/dl above baseline within 48 hours after AKI diagnosis. Persistent AKI was defined as need for renal replacement or no sCr recovery. Urine was obtained at intensive care unit (ICU) admission, and at 12 and 24 hours after admission; and urine Ba levels were quantitated via enzyme-linked immunosorbent assay and natural log transformed. Regression analyses were performed to test the association between urine Ba and organ failure outcomes. We adjusted for age and the acute physiology and chronic health evaluation II (APACHE-II) score, which is used to classify ICU severity of illness. RESULTS: A total of 439 patients were included: 252 without AKI, 124 with stage 1 AKI, 43 with stage 2 AKI, and 20 with stage 3 AKI. After adjusting for covariates, urine Ba increased as AKI stage increased. Urine Ba was higher in patients with persistent AKI compared with patients with AKI recovery and without AKI. Increased urine Ba was associated with worse organ failure outcomes (fewer ventilator, ICU, and inotrope-free days, and fewer days alive). CONCLUSION: Urine Ba is increased in patients with severe AKI and discriminates between patients who have AKI recovery and patients who develop persistent AKI. A doubling of urine Ba was associated with a 6.6-fold increased odds of persistent AKI. Future studies to validate these findings and to trial complement factor B inhibition are warranted.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Stenson EK, Edelstein CE, You Z, et al. Urine Complement Factor Ba Identifies Persistent Acute Kidney Injury and Organ Failures in Critically Ill Adults. Kidney Int Rep. 2024. PMID: 39990891. doi:10.1016/j.ekir.2024.11.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。